AbCellera Biologics, Inc. (ABCL)
4.43
+0.28
(+6.75%)
USD |
NASDAQ |
May 01, 16:00
4.42
-0.01
(-0.23%)
After-Hours: 20:00
AbCellera Biologics Market Cap : 1.352B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Achieve Life Sciences, Inc. | 233.19M |
| Aurinia Pharmaceuticals, Inc. | 2.041B |
| Edesa Biotech, Inc. | 146.59M |
| Lexaria Bioscience Corp. | 17.63M |
| Sirona Biochem Corp. | 1.320M |
Market Cap Related Metrics
| PS Ratio | 17.63 |
| Price to Book Value | 1.399 |
| Price | 4.43 |
| Earnings Yield | -11.07% |